Bioforce Nanosciences Holdings BFNH Cash Flow Statement (2019-2026)

OTC BFNH
$7.41 -0.78 (-9.52%)
At close: Oct 27, 2026 · 4:00 PM EDT
Reported Financials

Bioforce Nanosciences Holdings Quarterly Cash Flow Statement

Periods 27 quarters
Latest Jun 2026

Bioforce Nanosciences Holdings reported cash from operations of -$0.03M and free cash flow of -$0.03M for the quarter ended Jun 2026, up 3.3% year over year. This cash flow statement covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-0.11M-0.12M-0.13M-0.12M-0.12M-0.11M-0.13M-0.11M-0.11M-0.11M-0.13M-0.11M-0.12M-0.12M-0.93M-0.12M-0.12M-0.12M-0.10M0.24M
Share-based CompensationStock Comp.
Other non-cash itemsOther Non-Cash
0.80M-0.50M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in Accrued ExpensesChange Accrued Exp.
0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.10M0.11M0.10M-0.01M
Change in Other Operating AssetsOther Assets Change
-30.00-30.00-30.00-10.00
Other Working Capital ChangesOther WC Changes
30.0030.0030.0010.00
Cash from OperationsCash from Ops.
-0.01M-0.01M-0.03M-0.01M-0.02M-0.01M-0.02M-0.01M-0.01M-0.01M-0.02M-0.01M-0.02M-0.01M-0.02M-0.03M-0.01M-0.01M0.01M-0.03M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.01M-0.01M0.03M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.03M0.01M0.01M0.01M
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.01M-0.01M0.03M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.03M0.01M0.01M0.01M0.00M0.02M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.01M-0.01M0.03M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.03M0.01M0.01M0.01M0.00M0.02M
Cash from Financing ActivitiesCash from Financing
0.01M-0.01M0.03M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.02M0.01M0.02M0.01M0.03M0.01M0.01M0.01M0.00M0.02M
Additional items
Change in Cash
-0.02M-0.01M-16.00-48.00-32.0032.00-48.002.0027.00968.00-773.000.01M-0.01M-121.002.000.01M-0.01M
Ending Cash Balance
0.03M0.01M0.01M0.01M750.00734.00686.00654.00686.00638.00640.00667.000.00M862.000.01M905.00784.00786.000.01M307.00
Free Cash FlowFCF
-0.01M-0.01M-0.03M-0.01M-0.02M-0.01M-0.02M-0.01M-0.01M-0.01M-0.02M-0.01M-0.02M-0.01M-0.02M-0.03M-0.01M-0.01M0.01M-0.03M
Net Cash FlowNCF
-0.02M0.00M-0.01M-16.00-48.00-32.0032.00-48.002.0027.00968.00-773.000.01M-0.01M-121.002.000.01M-0.01M

Bioforce Nanosciences Holdings Cash Flow Statement API

Pull Bioforce Nanosciences Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BFNH&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY